JP2025501214A5 - - Google Patents

Info

Publication number
JP2025501214A5
JP2025501214A5 JP2024539426A JP2024539426A JP2025501214A5 JP 2025501214 A5 JP2025501214 A5 JP 2025501214A5 JP 2024539426 A JP2024539426 A JP 2024539426A JP 2024539426 A JP2024539426 A JP 2024539426A JP 2025501214 A5 JP2025501214 A5 JP 2025501214A5
Authority
JP
Japan
Prior art keywords
ipsc
antigen
domain
seq
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024539426A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501214A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/082441 external-priority patent/WO2023129937A1/en
Publication of JP2025501214A publication Critical patent/JP2025501214A/ja
Publication of JP2025501214A5 publication Critical patent/JP2025501214A5/ja
Pending legal-status Critical Current

Links

JP2024539426A 2021-12-29 2022-12-27 抗cd19/抗cd22キメラ抗原受容体を有する遺伝子操作細胞、およびその使用 Pending JP2025501214A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163294618P 2021-12-29 2021-12-29
US63/294,618 2021-12-29
US202263350156P 2022-06-08 2022-06-08
US63/350,156 2022-06-08
PCT/US2022/082441 WO2023129937A1 (en) 2021-12-29 2022-12-27 Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof

Publications (2)

Publication Number Publication Date
JP2025501214A JP2025501214A (ja) 2025-01-17
JP2025501214A5 true JP2025501214A5 (cg-RX-API-DMAC10.html) 2026-01-13

Family

ID=85222536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024539426A Pending JP2025501214A (ja) 2021-12-29 2022-12-27 抗cd19/抗cd22キメラ抗原受容体を有する遺伝子操作細胞、およびその使用

Country Status (7)

Country Link
US (1) US20250064934A1 (cg-RX-API-DMAC10.html)
EP (1) EP4456912A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025501214A (cg-RX-API-DMAC10.html)
AU (1) AU2022423987A1 (cg-RX-API-DMAC10.html)
CA (1) CA3243966A1 (cg-RX-API-DMAC10.html)
TW (1) TW202342734A (cg-RX-API-DMAC10.html)
WO (1) WO2023129937A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250090582A1 (en) * 2022-06-08 2025-03-20 Century Therapeutics, Inc. Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof
CN120435498A (zh) * 2022-11-10 2025-08-05 世纪治疗股份有限公司 具有抗-nectin4嵌合抗原受体的基因工程化细胞及其用途
WO2025207795A1 (en) * 2024-03-26 2025-10-02 Juno Therapeutics, Inc. Genetically engineered cells having anti-cd33 / anti-cd123 chimeric antigen receptors, and uses thereof
WO2025207798A1 (en) * 2024-03-26 2025-10-02 Century Therapeutics, Inc. Genetically engineered cells having anti-cd123 chimeric antigen receptors, and uses thereof
WO2025214438A1 (zh) * 2024-04-10 2025-10-16 浙江纳米抗体技术中心有限公司 结合cd19和/或cd22的抗原结合分子及其用途
CN121537531B (zh) * 2026-01-16 2026-07-21 北京肿瘤医院(北京大学肿瘤医院) 一种表达cd47-cd28共刺激转换受体的嵌合抗原受体及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US8846395B2 (en) 2005-06-01 2014-09-30 Wisconsin Alumni Research Foundation Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors
KR100902340B1 (ko) 2007-08-02 2009-06-12 한국생명공학연구원 Yc-1 또는 il-21을 유효성분으로 포함하는자연살해세포 분화제 및 분화 방법
ES2587395T3 (es) 2008-06-04 2016-10-24 Cellular Dynamics International, Inc. Procedimientos para la producción de células IPS usando un enfoque no vírico
JP5652783B2 (ja) 2008-09-08 2015-01-14 独立行政法人理化学研究所 NKT細胞由来iPS細胞およびそれ由来のNKT細胞
CA2753679C (en) 2009-02-27 2021-03-02 Cellular Dynamics International, Inc. Differentiation of pluripotent cells
PT2816112T (pt) 2009-12-10 2018-11-20 Univ Iowa State Res Found Inc Modificação do adn modificada pelo efector tal
EP2601289B1 (en) 2010-08-04 2017-07-12 Cellular Dynamics International, Inc. Reprogramming immortalized b cells
WO2012109208A2 (en) 2011-02-08 2012-08-16 Cellular Dynamics International, Inc. Hematopoietic precursor cell production by programming
AU2015290554A1 (en) 2014-07-18 2017-03-09 Kyoto University Method for inducing T cells for cell-based immunotherapy from pluripotent stem cells
WO2017070333A1 (en) 2015-10-20 2017-04-27 Cellular Dynamics International, Inc. Multi-lineage hematopoietic precursor cell production by genetic programming
LT3444334T (lt) 2016-04-15 2021-12-10 Kyoto University Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas
JP7215994B2 (ja) 2016-09-06 2023-01-31 ザ チルドレンズ メディカル センター コーポレーション 人工多能性幹細胞由来の免疫細胞
KR102397771B1 (ko) 2016-09-23 2022-05-13 프레드 헛친슨 켄서 리서치 센터 부 조직적합성(h) 항원 ha-1에 대해서 특이적인 tcr 및 이의 용도
TW201908335A (zh) 2017-07-25 2019-03-01 美國德州系統大學評議委員會 增強之嵌合抗原受體及其用途
EP3684816B1 (en) 2017-09-22 2024-05-29 Kite Pharma, Inc. Chimeric polypeptides and uses thereof
EP3692057B9 (en) 2017-10-03 2023-10-04 Precision BioSciences, Inc. Modified epidermal growth factor receptor peptides for use in genetically-modified cells
CA3091158A1 (en) 2018-02-14 2019-08-22 Sunnybrook Research Institute Method for generating cells of the t cell lineage
WO2020069184A2 (en) * 2018-09-26 2020-04-02 Lentigen Technology, Inc. Compositions and methods for treating cancer with anti-cd19/cd22 immunotherapy
EP4041759A4 (en) * 2019-10-07 2023-12-20 Fate Therapeutics, Inc. IMPROVED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTIVE CELL ENGINEERING AND ITS USE
WO2021092252A1 (en) * 2019-11-05 2021-05-14 Forman Stephen J Generation of chimeric antigen receptor modified t cells from stem cells and therapeutic uses thereof
JP7805928B2 (ja) * 2019-11-26 2026-01-26 ノバルティス アーゲー Cd19及びcd22キメラ抗原受容体及びその使用
WO2021188599A1 (en) * 2020-03-16 2021-09-23 University Of Southern California Novel antigen binding domains and synthetic antigen receptors incorporating the same
KR20230040337A (ko) * 2020-06-19 2023-03-22 페이트 세러퓨틱스, 인코포레이티드 면역요법 사용을 위한 iPSC-유래 이펙터 세포 유형들의 조합
TW202241935A (zh) * 2020-12-18 2022-11-01 美商世紀治療股份有限公司 具有可調適受體專一性之嵌合抗原受體系統

Similar Documents

Publication Publication Date Title
JP7745032B2 (ja) 一本鎖および多鎖キメラポリペプチドならびにその使用方法
JP7781243B2 (ja) ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法
JP2024519515A5 (cg-RX-API-DMAC10.html)
JP2023553419A5 (cg-RX-API-DMAC10.html)
JP7091447B2 (ja) 新型なscFvアミノ酸配列、それを含むキメラ抗原受容体、およびその使用
JP6499245B2 (ja) 形質導入T細胞選択のためのトランケート上皮増殖因子レセプタ(EGFRt)
CN112469829B (zh) 包含抗gpc3单链抗体的car
JP2024513906A5 (cg-RX-API-DMAC10.html)
US12060394B2 (en) Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof
CN107660213B (zh) 人源化抗MUCl*抗体
US11957717B2 (en) Anti-human MSLN antibody and MSLN-targeting immune effector cell
CN112955465A (zh) 抗tcr抗体分子及其用途
CN116234829A (zh) 抗tcr抗体分子及其用途
JP2023515211A5 (cg-RX-API-DMAC10.html)
KR20210019993A (ko) Τ 세포 수용체 및 이를 발현하는 조작된 세포
JP2022553818A (ja) 二重標的キメラ抗原レセプターt細胞療法のためのプロテアーゼスイッチ
KR102316091B1 (ko) Bcma를 표적으로 하는 키메라 항원 수용체 및 이의 용도
CN111556756A (zh) 重组免疫细胞、制备方法和使用方法
CN117597359A (zh) 与tcr结合的多功能分子及其用途
CN118786150A (zh) 与tcr结合的多功能分子及其用途
TW201905198A (zh) 用於降低嵌合刻痕受體之免疫原性的方法與組合物
JP2023515747A (ja) 免疫調節分子を発現する細胞および免疫調節分子を発現するための系
RU99101121A (ru) Полипептиды, способные к образованию антигенсвязывающих структур со специфичностью к резус-d-антигенам, днк, кодирующая их, способы их получения и применение
EP4061385A1 (en) A method for redesign and expansion of nk92 cells for use in immunotherapy
WO2021115333A1 (zh) 一种融合蛋白及表达此蛋白的工程化免疫细胞及其应用